Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection
Last Updated: June 5, 2017
Status: Current
Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection
Products Affected - Description
-
All presentations are currently available
Reason for the Shortage
-
- Pfizer had Precedex premixed bottles on shortage due to manufacturing delays.
- Dexmedetomidine 100 mcg/mL vials are not affected by this shortage.
Available Products
-
Precedex in 0.9% Sodium Chloride Injection solution for injection, Pfizer
4 mcg/mL, 20 mL glass vial, 10 count (NDC 00409-1660-20)
4 mcg/mL, 50 mL glass bottle, 20 count (NDC 00409-1660-50)
4 mcg/mL, 100 mL glass bottle, 10 count (NDC 00409-1660-10)
Estimated Resupply Dates
-
Pfizer has Precedex 4 mcg/mL premixed bottles available.
Related Shortages
| Amobarbital Injection | Resolved |
| Chloral Hydrate Oral Solution and Capsules | No Longer Available |
| Dexmedetomidine Injection | Resolved |
| Droperidol Injection | No Longer Available No Commercially Available Preparations |
| Hydroxyzine Hydrochloride Injection | Current |
| Lorazepam Injection | Current |
| Midazolam Injections | Resolved |
| Zolpidem Tartrate Immediate Release Tablets | Resolved |
Updated
June 5, May 19 and 2, April 3, February 22, 2017, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
